Valneva Stock News & Updates
[WKN: A0MVJZ | Symbol: AYJ]
Valneva SE: Progress on Lyme Disease Vaccine Sparks Buying Interest!
Recently, speculative investors have shown renewed interest in biotechnology stocks on international...
Valneva SE: Setback with one Vaccine and Success News with Another!
Among European biotechs, Valneva SE (i.) has been making headlines since July with its strength. The...
Valneva SE: Revenue From Chikungunya Vaccine has Nearly Eightfolded - Pipeline Offers Even More!
Among the speculative European biotechs, Valneva SE (i.) has distinguished itself as one of the leaders...
Valneva SE: Chikungunya Vaccine Triggers Trend Reversal!
The biotech company Valneva has established a strong position with vaccines for infectious diseases with...
Analysts' Top 5 Price Targets of July 29, 2025
Redcare Pharmacy N.V. [NL0012044747] Jefferies reaffirms Buy rating with a price target of €170 (54%...
Valneva SE: Market Leadership of Selected Vaccines Impresses Investors!
Valneva SE (i.) is a specialized biotechnology company focused on the development and marketing of vaccines...
Valneva SE: Investors Capitalize on Panic to Focus on the Long-Term Story!
On April 7, the overall market was panic-sold due to the uncertain developments regarding US tariff policy...
Valneva SE: Vaccine Candidates With Blockbuster Potential!
Valneva SE (i.) is a European biotechnology company that specializes in vaccines for diseases such as...
Valneva: Contract From the US Department of Defense and Market approval for Chikungunya Vaccine in the UK!
The biopharmaceutical company Valneva SE has faced some significant setbacks in the past, particularly...
Valneva SE: New Order from the U.S. Department of Defense for Vaccine Against JE!
Valneva SE is a biotechnology company focused on the development and marketing of vaccines against infectious...
- ‹
- 1
- ›